Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.69 |
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | RXRA | P19793 | 1/20 | 0.53 |
| ▸ | RXRB | P28702 | 1/20 | 0.53 |
| ▸ | RXRG | P48443 | 1/20 | 0.53 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8752667 | 0.91 | TSHR (0.68) | LMNATSHRTDP1L3MBTL1RXRA | |
| SCHEMBL3043854 | 0.89 | TSHR (0.61) | LMNATSHRTDP1L3MBTL1RXRA | |
| SCHEMBL8355272 | 0.88 | TSHR (0.59) | LMNATSHRTDP1ALDH1A1KMT2A | |
| SCHEMBL22782667 | 0.88 | TSHR (0.59) | LMNATSHRTDP1ALDH1A1KMT2A | |
| SCHEMBL3723813 | 0.86 | PPARG (0.66) | LMNATSHRTDP1L3MBTL1RXRA | |
| SCHEMBL8948910 | 0.84 | RXRA (0.53) | LMNATSHRTDP1L3MBTL1RXRA | |
| SCHEMBL28261344 | 0.84 | TDP1 (0.53) | LMNATDP1L3MBTL1ALDH1A1KDM4E | |
| SCHEMBL25166438 | 0.83 | LMNA (0.57) | LMNATSHRTDP1L3MBTL1RXRA | |
| SCHEMBL30330357 | 0.83 | LMNA (0.57) | LMNATSHRTDP1L3MBTL1RXRA | |
| SCHEMBL16404614 | 0.83 | LMNA (0.57) | LMNATSHRTDP1L3MBTL1RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113493870-B | Composite flocculant for ion type rare earth enrichment and enrichment method | 福建省长汀金龙稀土有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-113493870-A | Composite flocculant for ion type rare earth enrichment and enrichment method | 厦门钨业股份有限公司 | 2021-10-12 | — | — | CN | claimed |
| EP-4626865-A1 | CYCLIC PYRAZOLE DIAMIDE IRE1/XBP1S ACTIVATORS | Protego Biopharma, Inc. (US) | 2025-10-08 | — | — | EP | disclosed |
| WO-2024118810-A1 | CYCLIC PYRAZOLE DIAMIDE IRE1/XBP1S ACTIVATORS | PROTEGO BIOPHARMA, INC. (US) | 2024-06-06 | — | — | WO | disclosed |
| CN-113493870-B | Composite flocculant for ion type rare earth enrichment and enrichment method | 福建省长汀金龙稀土有限公司 | 2023-04-07 | — | — | CN | disclosed |
| CN-113493874-B | Method for purifying high-purity scandium salt | 福建省长汀金龙稀土有限公司 | 2022-12-13 | — | — | CN | disclosed |
| CN-113493870-A | Composite flocculant for ion type rare earth enrichment and enrichment method | 厦门钨业股份有限公司 | 2021-10-12 | — | — | CN | disclosed |
| CN-113493874-A | Method for purifying high-purity scandium salt | 厦门钨业股份有限公司 | 2021-10-12 | — | — | CN | disclosed |
| US-11060079-B2 | Methods and microorganisms for producing flavors and fragrance chemicals | ARDRA INC. (CA) | 2021-07-13 | — | — | US | disclosed |
| WO-2021108628-A1 | SUBSTITUTED MACROCYCLIC COMPOUNDS AND RELATED METHODS OF TREATMENT | ALKERMES, INC. (US) | 2021-06-03 | — | — | WO | disclosed |
| US-20190177713-A1 | METHODS AND MICROORGANISMS FOR PRODUCING FLAVORS AND FRAGRANCE CHEMICALS | ARDRA INC. (CA) | 2019-06-13 | — | — | US | disclosed |
| US-20080119465-A1 | Novel Indoline Compounds | LABORATORIES FOURNIER S.A. (FR) | 2008-05-22 | — | — | US | disclosed |
| WO-2007000550-A2 | NOVEL INDOLINE COMPOUNDS | LABORATOIRES FOURNIER S.A. (FR) | 2007-01-04 | — | — | WO | disclosed |
| EP-0554023-B1 | Corrosion inhibitors | CIBA GEIGY AG (CH) | 1997-04-23 | — | — | EP | disclosed |
| US-5250325-A | Corrosion inhibitors | CIBA-GEIGY CORPORATION (US) | 1993-10-05 | — | — | US | disclosed |
| EP-0554023-A1 | Corrosion inhibitors | CIBA-GEIGY AG (CH) | 1993-08-04 | — | — | EP | disclosed |
| US-4244731-A | APPLYING A CARBOXY DERIVATIVE OF A 2,6-DIMETHYLPHENOXY COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-01-13 | — | — | US | disclosed |
| US-4090862-A | Novel phenoxycarboxylic acid aryloxy(thio)carbonylaminomethyl esters and their use for regulating plant growth | BAYER AKTIENGESELLSCHAFT (DT) | 1978-05-23 | — | — | US | disclosed |
| US-4086240-A | 1-Thiazolyl-5-phenoxy and phenylthioalkanoyloxyimidazolidinones | VELSICOL CHEMICAL CORPORATION (US) | 1978-04-25 | — | — | US | disclosed |
| US-4053480-A | 1-THIADIAZOLYL-5-PHENOXY- AND PHENYLTHIOALKANOYLOXY IMIDAZOLIDINONES | VELSICOL CHEMICAL CORPORATION (US) | 1977-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119465-A1 | Novel Indoline Compounds | GPR119, INSR, IRS1 | LMNA 1943/4885TSHR 681/4885TDP1 779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.